THOUSAND OAKS, Calif.,
Oct. 4, 2016 /PRNewswire/
-- Amgen (NASDAQ:AMGN) will participate in a call hosted by
Citi at 8 a.m. PT on Friday, Oct. 7, 2016. Sean E. Harper, M.D., executive vice president
of Research and Development (R&D) at Amgen, will discuss recent
developments within the Company's R&D. Live audio of the
call can be accessed from the Events Calendar on Amgen's website,
www.amgen.com, under Investors. A replay of the webcast will also
be available on Amgen's website for at least 90 days following the
event.
About Amgen
Amgen is committed to unlocking the
potential of biology for patients suffering from serious illnesses
by discovering, developing, manufacturing and delivering innovative
human therapeutics. This approach begins by using tools like
advanced human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages
its expertise to strive for solutions that improve health outcomes
and dramatically improve people's lives. A biotechnology pioneer
since 1980, Amgen has grown to be one of the world's leading
independent biotechnology companies, has reached millions of
patients around the world and is developing a pipeline of medicines
with breakaway potential.
For more information, visit www.amgen.com and follow us on
www.twitter.com/amgen.
CONTACT: Amgen, Thousand
Oaks
Kristen Davis, 805-447-3008
(media)
Kristen Neese, 805-313-8267
(media)
Arvind Sood, 805-447-1060
(investors)
Logo
- http://photos.prnewswire.com/prnh/20081015/AMGENLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/amgen-to-participate-in-citi-biotech-rd-conference-call-300339149.html
SOURCE Amgen